ELOXATIN 5 mg/ml concentraat voor oplossing voor infusie

DRUG2 trials

Sponsors

Groupe Belge D'Oncologie Digestive, Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Conditions

Primary resectablehistologically confirmed gastric or gastro-esophageal junction adenocarcinomasmall bowel adenocarcinoma

Phase 2

Neoadjuvant capecitabine, oxaliplatin, docetaxel and atezolizumab in non-metastatic, resectable gastric and GE-junction cancer - de PANDA trial

RecruitingCTIS2024-519075-26-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichtinghistologically confirmed gastric or gastro-esophageal junction adenocarcinoma, Primary resectable

Start: 2018-02-27Target: 21Updated: 2024-11-21

Phase 3

BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of the Global Ballad pooled data analysis.

Not yet recruitingCTIS2024-518349-85-01

Groupe Belge D'Oncologie Digestivesmall bowel adenocarcinoma

Target: 30Updated: 2024-11-20